investigator_user
investigator
user
funding
collaborators
pending
menu
bell
message
arrow_up
arrow_down
filter
layers
globe
marker
add
arrow
close
download
edit
facebook
info
linkedin
minus
plus
save
share
search
sort
twitter
remove
user-plus
user-minus
Sign Up for Updates
Map
Countries
Cancer types
All cancers but non-melanoma skin cancer
Bladder
Brain, nervous system
Breast
Cervix uteri
Colorectum
Corpus uteri
Gallbladder
Hodgkin lymphoma
Kaposi sarcoma
Kidney, renal pelvis and ureter
Larynx
Leukaemia
Lip, oral cavity
Liver and intrahepatic bile ducts
Melanoma of skin
Multiple myeloma and immunoproliferative diseases
Nasopharynx
Non-Hodgkin lymphoma
Non-Melanoma skin cancer
Oesophagus
Other pharynx
Ovary
Pancreas
Prostate
Sarcoma
Stomach
Testis
Thymus
Thyroid
Trachea, bronchus and lung
Specialities
Hematology and hematologic malignancies
Palliative Care
Pathology
Pediatric oncology or childhood cancer
Radiation Oncology
Surgery / Surgical oncology
Blog
About
Login
Project leads
Collaborators
Mechanism and Inhibition of Collagenolytic Activity
Gregg B Fields
1 Collaborator(s)
Funding source
National Cancer Institute (NIH)
Follow
+ Project
+ Post
+ Event
Info
People
Posts
Ivano Bertini
University of Florence
Florence, Italy
Gregg B Fields
Torrey Pines Institute For Molecular Studies
San Diego, United States
Related projects
Lewis A Chodosh
Role of SNF1 Kinase HUNK in Breast Cancer Progression
Breast
Christina N Curtis
Integrated genomic analysis and multi-scale modeling of therapeutic resistance
Breast
Peter Blumberg
Molecular Mechanism of Action of Phorbol Ester
Melanoma of skin
Catherine T Yan
Lig4R278H contribution to HSC and IgH class switching defects and malignancies
Melanoma of skin
Dewi Harjanto
Does the RNA editor Apobec-1 shift microRNA targeting to a tumorigenic effect?
Melanoma of skin
Peter Choyke
Angiogenesis Imaging
Breast
Ekaterina Pletneva
Conformational Properties of Cytochrome c in Apoptosis
Melanoma of skin
Pumin Zhang
Spindle Assembly Checkpoint, Chromosome Stability, and Cancer
Melanoma of skin
Mary J Cloninger
Using Dendrimers to Design Multivalent Therapeutic Agents
Melanoma of skin
